Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: IL-37 protects against airway remodeling by reversing bronchial epithelial–mesenchymal transition via IL-24 signaling pathway in chronic asthma

Fig. 4

IL-37 attenuated IL-24-induced bronchial epithelial migration and EMT in vitro. a The effect of IL-24 with or without IL-37 on the migration of BEAS-2B cells was evaluated by Transwell assay. Scale bar = 100 μm (× 100). b Quantification of the Transwell assay showed the number of migrated cells. c Quantification of E-cadherin, vimentin and α-SMA mRNA expression in BEAS-2B cells treated with 100 ng/ml IL-24 for 24 h with or without 100 ng/ml IL-37 pretreatment for 8 h by RT–qPCR. Representative immunoblots (d) and quantification (e) of E-cadherin, vimentin, and α-SMA protein expression in BEAS-2B cells treated with 100 ng/ml IL-24 for 48 h with or without 100 ng/ml IL-37. Bar diagrams and data are presented as the mean ± standard deviation (SD) from three replicate experiments. * vs. control group; # vs. IL-24 group. *,#P < 0.05; **, ##P < 0.01; ***,###P < 0.001, ****,####P < 0.0001

Back to article page